首页 | 本学科首页   官方微博 | 高级检索  
     


The Biology of Chronic Myelogenous Leukemia: Implications for Imatinib Therapy
Affiliation:1. Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX.;2. Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX.;1. The University of Texas MD Anderson Cancer Center, Houston, TX, USA;2. University of Campinas, Distrito de Barao Geraldo, Campinas, Brazil;3. Hospital de Especialidades CMN La Raza, Instituto Mexicano del Seguro Social, Seris y Zaachila s/n, Colonia La Raza, Mexico, DF, Mexico;4. Banco Municipal de Sangre, Dpt. Clinicas Hematologicas, Hemato-Oncologia, Esq Pirineos, Caracas, DC, Venezuela;5. Hospital Britanico, Buenos Aires, Argentina;6. The Gujarat Cancer and Research Institute, Ahmedabad, India;7. Peking University People''s Hospital, Peking University Institute of Hematology, Beijing, China;8. Kidwai Memorial Institute of Oncology, Bangalore, India;9. HCG Curie Centre of Oncology, Bangalore, India;10. Russian Research Institute of Hematology and Transfusiology, St Petersburg, Russia;11. Universidade Federal de São Paulo, Hospital Santa Marcelina, São Paulo, Brazil;12. Shanghai Ruijin Hospital, Shanghai, China;13. Department of Haematology, Jagiellonian University Medical College, Kraków, Poland;14. University of São Paulo Medical School, São Paulo, Brazil;15. Guangzhou KingMed Center for Clinical Laboratory Co, Ltd, Guangzhou, Guangdong, China;p. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA;q. Novartis Healthcare Pvt Ltd, Raheja Mind Space, Hitech City Madhapur/Hyderabad, Rangareddy, India;r. Novartis Pharma SAS, Oncology Global Development & Global Medical Affairs, France;s. Charité - University of Medicine Berlin, Campus Virchow-Klinikum, Medizinische Klinik mS, Hämatologie und Onkologie, Berlin, Germany;1. Department of Hematology and Oncology, Baylor College of Medicine, Houston, TX;2. Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX;1. Center for Translational Research and Molecular Biology of Cancer, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland;2. Biosystems Group, Institute of Automatic Control, Silesian University of Technology, Gliwice, Poland;1. Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Austria;2. Ludwig Boltzmann Cluster Oncology, Medical University of Vienna, Austria;3. Department/Clinic for Companion Animals and Horses, Clinic for Small Animals, Clinical Unit of Internal Medicine, University of Veterinary Medicine Vienna, Austria;4. Department of Laboratory Medicine, Medical University of Vienna, Austria;5. Department of Internal Medicine II, Division of Angiology, Medical University of Vienna, Austria;6. Department of Internal Medicine III, Cardiology and Angiology, Medical University of Innsbruck, Austria;7. Medical Clinic III for Oncology, Haematology, Immunology and Rheumatology, University Hospital Bonn (UKB), Germany;1. Department of Microbiology and Immunology, School of Medicine, Temple University, Philadelphia, PA;2. Department of Medicine (Oncology, Hematology, and Stem Cell Transplantation), University Medical Center of Aachen, Aachen, Germany;3. Institute of Medical Informatics, University of Münster, Münster, Germany;4. Department of Clinical Cytology, Medical Center for Postgraduate Education, Warsaw, Poland;5. Abteilung für Hämatologie, Onkologie, Hämostaseologie, Universitätsklinikum Leipzig, Leipzig, Germany;6. Department of Hematology/Oncology, University of Münster, Münster, Germany;7. Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany;8. Division of Hematopoietic Stem Cell and Leukemia Research, Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA;9. Department of Immunology, Medical University of Warsaw, Warsaw, Poland;10. Department of Hematology, Institute of Hematology and Blood Transfusion, Warsaw, Poland;11. Paul O''Gorman Leukemia Research Centre, University of Glasgow, Glasgow, United Kingdom;12. Fels Institute for Cancer Research and Molecular Biology, School of Medicine, Temple University, Philadelphia, PA
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号